|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 403/12 | |
| C07D 403/04 | |||
| C07D 471/04 | |||
| C07D 487/04 | |||
| A61K 31/506 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2922828 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13857326.6 |
| Europos patento paraiškos padavimo data | 2013-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-07-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/071132 |
| Data | 2013-11-21 |
| (87) | Numeris | WO 2014/081906 |
| Data | 2014-05-30 |
| (30) | Numeris | Data | Šalis |
| 201261728907 P | 2012-11-21 | US |
| (72) |
LEE, Chang-Sun, US
BAIAZITOV, Ramil, US
CAO, Liangxian, US
DAVIS, Thomas, W., US
DU, Wu, US
LIU, Ronggang, US
MOON, Young-choon, US
PAGET, Steven, D., US
REN, Hongyu, US
SYDORENKO, Nadiya, US
WILDE, Richard, Gerald, US
|
| (73) |
PTC Therapeutics, Inc.,
100 Corporate Court Middlesex Business Center, South Plainfield, New Jersey 07080,
US
|
| (54) | 4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS FOR TREATING CANCER |
| 4,6-DIAMINO-PYRIMIDINE DERIVATIVES AS BMI-1 INHIBITORS FOR TREATING CANCER |